Literature DB >> 16424972

Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections.

E Velasco1, R Byington, C A S Martins, M Schirmer, L M C Dias, V M S C Gonçalves.   

Abstract

A total of 399 consecutive episodes of bloodstream infections in adult patients with haematologic malignancies and solid tumours were evaluated prospectively over a 26-month period, with the aim of determining the clinical characteristics and the microbiological profile of the patients relative to neutrophil count. The overall 30-day mortality rate was 32% (35% in non-neutropenic patients vs. 26% in neutropenic patients, p=0.05). Main diagnoses were solid tumours (33%) and lymphoma (29%). Most of the episodes of bloodstream infection (58%) occurred in non-neutropenic patients. Acute leukaemia and bone marrow transplantation predominated in the neutropenic group. Non-neutropenic patients tended to be older and to have a higher frequency of solid tumours and advanced or uncontrolled diseases. Indwelling central venous catheters were present in 51% of the episodes, with a predominance of long-term catheters in neutropenic haematologic patients. Concomitant infections were observed more frequently in non-neutropenic patients. There were 1,040 noninfectious comorbid conditions, most of which were present in non-neutropenic patients. The causative pathogens were predominantly gram-negative bacilli (56%). Escherichia coli and Klebsiella pneumoniae were isolated more frequently from neutropenic patients, while Staphylococcus aureus and Acinetobacter spp. were more frequent in non-neutropenic patients. Seventy-four percent of the episodes of candidaemia occurred in patients with central venous catheters, with non-albicans strains predominating. The results of this study highlight the heterogeneity of cancer patients with bloodstream infections and the value of stratifying risk factors and aetiologic agents according to neutrophil count.

Entities:  

Mesh:

Year:  2006        PMID: 16424972     DOI: 10.1007/s10096-005-0077-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

Review 1.  Measuring comorbidity in older cancer patients.

Authors:  M Extermann
Journal:  Eur J Cancer       Date:  2000-03       Impact factor: 9.162

Review 2.  Prognostic scoring systems for infectious diseases: their applicability to the care of older adults.

Authors:  Manisha Juthani-Mehta; Vincent J Quagliarello
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079

3.  Prognosis of infections in elderly patients with haematological diseases.

Authors:  F Rossini
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

4.  Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.

Authors:  R Feld; B DePauw; S Berman; A Keating; W Ho
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

5.  Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Authors:  L S Elting; E B Rubenstein; K V Rolston; G P Bodey
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

6.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D Pittet; D Tarara; R P Wenzel
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

7.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

8.  Management of fever in neutropenic patients with different risks of complications.

Authors:  Jean Klastersky
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

9.  The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.

Authors:  Linda S Elting; Catherine Cooksley; Mark Chambers; Scott B Cantor; Ellen Manzullo; Edward B Rubenstein
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

10.  The impact of antimicrobial resistance on health and economic outcomes.

Authors:  Sara E Cosgrove; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

View more
  26 in total

1.  Transposon Mutagenesis Screen of Klebsiella pneumoniae Identifies Multiple Genes Important for Resisting Antimicrobial Activities of Neutrophils in Mice.

Authors:  Michelle K Paczosa; Rebecca J Silver; Anne L McCabe; Albert K Tai; Colin H McLeish; David W Lazinski; Joan Mecsas
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation.

Authors:  Sabrina I Green; Nadim J Ajami; Li Ma; Nina M Poole; Roger E Price; Joseph F Petrosino; Anthony W Maresso
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

3.  Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium.

Authors:  Nina M Poole; Sabrina I Green; Anubama Rajan; Luz E Vela; Xi-Lei Zeng; Mary K Estes; Anthony W Maresso
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 4.  Bloodstream infections in patients with solid tumors.

Authors:  Carlota Gudiol; José María Aguado; Jordi Carratalà
Journal:  Virulence       Date:  2016-01-19       Impact factor: 5.882

5.  Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients.

Authors:  Cheol-In Kang; Jae-Hoon Song; Kwan Soo Ko; Doo Ryeon Chung; Kyong Ran Peck
Journal:  Support Care Cancer       Date:  2011-02-12       Impact factor: 3.603

Review 6.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

7.  Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia.

Authors:  Cheol-In Kang; Jae-Hoon Song; Doo Ryeon Chung; Kyong Ran Peck; Joon-Sup Yeom; Jun Seong Son; Yu Mi Wi
Journal:  Support Care Cancer       Date:  2011-12-23       Impact factor: 3.603

Review 8.  Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Authors:  Nursel Calik Basaran; Sibel Ascioglu
Journal:  Ther Adv Infect Dis       Date:  2017-10-17

Review 9.  The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.

Authors:  Sohn Kim; April Covington; Eric G Pamer
Journal:  Immunol Rev       Date:  2017-09       Impact factor: 12.988

10.  Expression of CD11b/CD18 adhesion molecules on circulating phagocytes-a novel aid to diagnose infection in patients with cancer.

Authors:  R Kallio; H Aalto; A Takala; P Ohtonen; J Collan; S Siitonen; H Joensuu; H Syrjala; H Repo
Journal:  Support Care Cancer       Date:  2008-04-15       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.